Cancer Advocates Celebrate as Governor Signs “Jill’s Law” for Biomarker Testing Coverage
JACKSON, Miss. – Cancer advocates are celebrating after Gov.
ACS CAN Calls for Harmonizing and Modernizing Regulatory Framework for Diagnostic Tests
March 21, 2024
WASHINGTON, D.C. –Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule. The statement reads in part:
“Our preference is for Congress to pass legislation to modernize and harmonize diagnostics oversight, and we have supported the Verifying Accurate, Leading-edge IVCT Development (VALID) Act as a way to achieve that reform. However, until legislation is passed, we believe that taking a regulatory approach to harmonization is appropriate. We encourage Congress to move forward with legislation and look forward to working with you.”
Read the full statement here.
More Press Releases About